Due to the ability to inhibit anti-tumor immunity, tumor-infiltrating Foxp3+ Tregs were associated with poor prognosis [36], but recently, it has been shown that Foxp3+Tregs could improve survival in some tumors [37,38]. This evidence concerns the gene FOXP3 and neoplasm.